Revvity, Inc.

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP

714046109
SEDOL

BYZHBH7
CIK

0000031791

www.revvity.com
LEI:
FIGI: BBG000FXW512
RVTY

Revvity, Inc.
GICS: 35203010 · Sector: Healthcare · Sub-Sector: Diagnostics & Research
AI
PROFILER
NAME
Revvity, Inc.
ISIN
US7140461093
TICKER
RVTY
MIC
XNYS
REUTERS
RVTY.N
BLOOMBERG
RVTY US
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Mon, 13.01.2025       Revvity
US7140461093

Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life science company democratizing access to advanced DNA and multi-omic sequencing solutions. This initiative builds upon Revvity's recent introdu...
Wed, 20.11.2024       Revvity
US7140461093

Revvity, Inc. (NYSE: RVTY), today announced an expansion of its work with Genomics England that leverages both organizations' expertise and resources to advance critical genomic initiatives across the United Kingdom. Building on the parties’ long and productive work history, this advanced collaboration is dedicated to accelerating Genomics England...
Tue, 19.11.2024       Revvity
US7140461093

Scale Biosciences (Scale BioTM), a leader in innovative and scalable single cell analysis solutions, and Revvity’s (NYSE: RVTY) BioLegend business, a leading provider of world-class biological reagents and tools, today announced the availability of a new, first-of-its-kind TotalSeqTM PhenocyteTM single-cell protein profiling solution that supports...
Tue, 22.10.2024       Revvity
US7140461093

Revvity, Inc. (NYSE: RVTY) today announced the launch of Revvity Transcribe AI, an innovative optical character recognition (OCR) service designed to convert handwritten text on test request forms into a digitized format. This cutting-edge solution is now available to clinical laboratories, aiming to streamline workflows and reduce manual data ent...
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S